Lexaria Bioscience Corp (LEXX)

NASDAQ

Currency in USD

LEXX Pro Research

3.280

-0.090(-2.67%)

Closed·25/09

Pre Market

3.210-0.070(-2.13%)

·07:58:47

Fair Value

Unlock Value

Day's Range

3.150

3.455

52 wk Range

0.560

21.600

LEXX Income Statement

Assess the Lexaria Bioscience income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the LEXX net worth.

Period Ending:

2016

31/08

2017

31/08

2018

31/08

2019

31/08

2020

31/08

2021

31/08

2022

31/08

2023

31/08

2024

31/08

2025

31/08

Total Revenues

aa.aa

0.72

0.26

0.23

0.46

0.71

Total Revenues Growth

aa.aa

+129.59%

-64.66%

-11.43%

+105.24%

+52.05%

Cost Of Revenues

aa.aa

0.18

0.07

0.03

Gross Profit

aa.aa

0.55

0.18

0.19

0.46

0.7

Gross Profit Growth

aa.aa

+154.11%

-66.47%

+6.08%

+135.97%

+53.05%

Gross Profit Margin %

aa.aa

75.74%

71.87%

86.07%

98.96%

99.61%

Other Operating Expenses, Total

aa.aa

6.23

6.8

6.62

6.15

12.34

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+42.85%	+9.12%	-2.66%	-7.06%	+100.44%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.26	1.84	3.67	2.36	8.24
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4.97	4.96	2.96	3.79	4.1
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-5.69

-6.62

-6.43

-5.7

-11.63

Operating Income Growth

aa.aa

-37.07%

-16.39%

+2.9%

+11.39%

-104.26%

EBIT Margin %

aa.aa

-786.85%

-2,591.67%

-2,841.31%

-1,226.7%

-1,647.97%

Net Interest Expenses

aa.aa

0.04

0.01

Net Interest Expenses Growth

aa.aa

-66.87%

-78.92%

Interest Expense, Total

aa.aa

Interest And Investment Income

aa.aa

0.04

0.01

Other Non Operating Expenses, Total

aa.aa

EBT, Excl. Unusual Items

aa.aa

-5.69

-6.62

-6.38

-5.68

-11.63

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-0.11

-0.06

-0.25

EBT, Incl. Unusual Items

aa.aa

-5.69

-7.38

-6.71

-5.81

-11.91

EBT, Incl. Unusual Items Growth

aa.aa

-37.07%

-29.84%

+9.09%

+13.47%

-105.06%

EBT, Incl. Unusual Items Margin

aa.aa

-786.85%

-2,891.05%

-2,967.41%

-1,251.12%

-1,687.36%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-4.19

-7.38

-6.71

-5.81

-11.91

Minority Interest

aa.aa

0.16

0.11

0.05

0.01

Net Income

aa.aa

-4.03

-7.27

-6.66

-5.8

-11.9

Net Income Growth

aa.aa

-2.36%

-80.51%

+8.31%

+13.05%

-105.37%

Net Income Margin %

aa.aa

-557.19%

-2,846.28%

-2,946.36%

-1,248.25%

-1,686%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-5.53

-7.27

-6.66

-5.8

-11.9

Basic EPS - Continuing Operations

aa.aa

-18.88

-18.53

-15.12

-7.02

-9.92

Basic EPS - Continuing Operations Growth

aa.aa

+12.69%

+1.87%

+18.42%

+53.56%

-41.3%

Diluted EPS - Continuing Operations

aa.aa

-18.88

-18.53

-15.12

-7.02

-9.92

Diluted EPS - Continuing Operations Growth

aa.aa

+12.69%

+1.87%

+18.42%

+53.56%

-41.3%

Basic Weighted Average Shares Outstanding

aa.aa

0.29

0.39

0.44

0.83

1.2

Diluted Weighted Average Shares Outstanding

aa.aa

0.29

0.39

0.44

0.83

1.2

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-5.58

-6.52

-6.28

-5.62

-11.55

EBITDA Growth

aa.aa

-38.13%

-16.88%

+3.6%

+10.55%

-105.47%

EBITDA Margin %

aa.aa

-771.39%

-2,551.45%

-2,777.03%

-1,210.3%

-1,635.53%

EBIT

aa.aa

-5.69

-6.62

-6.43

-5.7

-11.63

* In Millions of USD (except for per share items)

FAQ

What was Lexaria Bioscience’s revenue at year end?

At the end of the last reported fiscal year, Lexaria Bioscience (LEXX) recorded total revenue of 0.706 million USD.

What was Lexaria Bioscience’s net income for the year?

For the full year, Lexaria Bioscience reported net income of -11.902 million USD.

How much net income did Lexaria Bioscience post in the last quarter?

In the most recent quarter, Lexaria Bioscience (LEXX) posted net income of -1.991 million USD.

What was Lexaria Bioscience’s gross profit for the year?

Gross profit for the year was reported at 0.703 million USD.

What was Lexaria Bioscience’s annual operating income?

For the full year, Lexaria Bioscience (LEXX) reported operating income of -11.633 million USD.

What was Lexaria Bioscience’s operating income last quarter?

Quarterly operating income was -1.994 million USD.

What was Lexaria Bioscience’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -1.975 million USD.

What was the quarter-over-quarter change in EBITDA for Lexaria Bioscience?

EBITDA changed by -37.814% million USD compared to the last quarter.

S&P/TSX

35,800.89

+94.43

+0.26%

S&P/TSX 60

2,102.44

+5.54

+0.26%

US 30

51,579.30

-249.3

-0.48%

US 500

7,718.80

-24.7

-0.32%

S&P 500 VIX

16.00

+1.13

+7.60%

DAX

25,493.31

+97.09

+0.38%

Dollar Index

100.923

+0.215

+0.21%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	67.17	-0.96%	12.92M
RBC	285.63	+1.25%	2.39M
National Bank of Canada	212.23	+1.35%	2.81M
TC Energy	83.17	-1.29%	6.74M
Toronto Dominion Bank	170.69	+1.20%	2.81M
Enbridge	66.13	-1.28%	6.58M
Suncor Energy	96.57	-0.45%	3.32M

Name	Last	Chg. %	Vol.
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Greenhawk Resources	0.02	+100.00%	132.40K
Ramm Pharma	0.01	+100.00%	50.00K
Nuinsco Resources	0.0100	+100.00%	33.00K
Greenhawk Resources	0.0200	+100.00%	132.40K
Psyched Wellness	0.01	+100.00%	2.00K

Name	Last	Chg. %	Vol.
Playground Ventures	0.005	-66.67%	1.00K
Lanebury Growth Capital	0.06	-63.33%	4.00K
Molecule Holdings	0.005	-50.00%	20.11K
Hanstone Gold	0.02	-50.00%	13.00K
Enerev5 Metals	0.0050	-50.00%	5.00K
Affinity Metals	0.025	-50.00%	2.00K
Playgon Games	0.0050	-50.00%	1.12K

Trending Stocks

Name	Last	Chg. %	Vol.
Air Canada	27.34	-5.59%	4.81M
Equinox Gold	16.87	+1.81%	2.27M
BCE Inc	29.69	-1.53%	5.48M
Toronto Dominion Bank	170.69	+1.20%	2.81M
HIVE Digital Tech	4.4600	-4.29%	2.00M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaa	16.64	+72.80%	28.75
Aaaaaa Aaaaaaaa Aa	16.74	+57.16%	26.31
Aaaaaaa Aaaaaaaa	95.84	+55.57%	149.10
Aaa Aaaaaaaaaaa	2.2700	+53.82%	3.4917
Aaaa Aaaaaa	15.56	+52.98%	23.80
Aaaaaaaaaaa Aaaaa	113.31	+50.70%	170.76
Aa Aaa	1.510	+48.45%	2.241

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaa	16.64	+72.80%	28.75
Aaaaaa Aaaaaaaa Aa	16.74	+57.16%	26.31
Aaaaaaa Aaaaaaaa	95.84	+55.57%	149.10
Aaa Aaaaaaaaaaa	2.2700	+53.82%	3.4917
Aaaa Aaaaaa	15.56	+52.98%	23.80
Aaaaaaaaaaa Aaaaa	113.31	+50.70%	170.76
Aa Aaa	1.510	+48.45%	2.241

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Lexaria Bioscience Corp (LEXX)

LEXX Income Statement

FAQ

What was Lexaria Bioscience’s revenue at year end?

What was Lexaria Bioscience’s net income for the year?

How much net income did Lexaria Bioscience post in the last quarter?

What was Lexaria Bioscience’s gross profit for the year?

What was Lexaria Bioscience’s annual operating income?

What was Lexaria Bioscience’s operating income last quarter?

What was Lexaria Bioscience’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Lexaria Bioscience?

Trending Stocks